---
title: "Hengrui Pharma falls nearly 4% in Hong Kong trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305915630.md"
description: "Hengrui Pharma fell 3.94% to HK$45.78. Down 11.36% over ten sessions and down 35.54% YTD."
datetime: "2026-11-18T05:02:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305915630.md)
  - [en](https://longbridge.com/en/news/305915630.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305915630.md)
generator: "portal-rs"
---

# Hengrui Pharma falls nearly 4% in Hong Kong trading

Hengrui Pharma (1276.HK) fell nearly **4%** in Hong Kong trading, last at **HK$45.78**.

The stock is down 11.36% over the past ten sessions and down 35.54% year to date. It sits 43.29% below its 52-week high of HK$80.72.

The Hang Seng Index is down 4.48% over the past five sessions and down 9.38% year to date.

The pharmaceuticals industry index fell 2.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)

## Related News & Research

- [Hengrui Announces Drug Inclusions in China’s 2026 NRDL](https://longbridge.com/en/news/305570916.md)
- [Hengrui Pharma reports 88.9% rise in 2026 third-quarter profit on licensing deals](https://longbridge.com/en/news/303205414.md)
- [Alibaba Q2 revenue rises on AI Cloud and Compute Services strength](https://longbridge.com/en/news/306100634.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [Moonshot drops $150M Indonesia Nvidia rental days after US loophole crackdown](https://longbridge.com/en/news/306145817.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**